+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5189610
  • Report
  • October 2020
  • Region: Global
  • 420 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • Caprion Biosciences Inc
  • Fluxion Biosciences Inc
  • MDxHealth SA
  • PreMD Inc (Inactive)
  • Trinity College Dublin
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020“. Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Breast Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • Caprion Biosciences Inc
  • Fluxion Biosciences Inc
  • MDxHealth SA
  • PreMD Inc (Inactive)
  • Trinity College Dublin

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Breast Cancer Overview
3 Products under Development
3.1 Breast Cancer - Pipeline Products by Stage of Development
3.2 Breast Cancer - Pipeline Products by Territory
3.3 Breast Cancer - Pipeline Products by Regulatory Path
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer - Ongoing Clinical Trials
4 Breast Cancer - Pipeline Products under Development by Companies
4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer - Pipeline Products by Stage of Development
5 Breast Cancer Companies and Product Overview6 Breast Cancer- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
List of Tables
Table 1: Breast Cancer - Pipeline Products by Stage of Development
Table 2: Breast Cancer - Pipeline Products by Territory
Table 3: Breast Cancer - Pipeline Products by Regulatory Path
Table 4: Breast Cancer - Pipeline Products by Estimated Approval Date
Table 5: Breast Cancer - Ongoing Clinical Trials
Table 6: Breast Cancer Companies - Pipeline Products by Stage of Development
Table 7: Breast Cancer - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Onco 88 - Breast Cancer - Product Status
Table 10: Onco 88 - Breast Cancer - Product Description
Table 11: OncoStain 88 - Breast Cancer - Product Status
Table 12: OncoStain 88 - Breast Cancer - Product Description
Table 13: Abviva Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Mammastatin Serum Assay - Product Status
Table 15: Mammastatin Serum Assay - Product Description
Table 16: Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Companion Diagnostic Test - Oxaliplatin - Product Status
Table 18: Companion Diagnostic Test - Oxaliplatin - Product Description
Table 19: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Companion Diagnostic Test - Breast Cancer - Product Status
Table 21: Companion Diagnostic Test - Breast Cancer - Product Description
Table 22: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
Table 23: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
Table 24: Diagnostic/Prognostic Assay - Breast Cancer - Product Status
Table 25: Diagnostic/Prognostic Assay - Breast Cancer - Product Description
Table 26: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AF300 Based Chromatographic Kit - Product Status
Table 28: AF300 Based Chromatographic Kit - Product Description
Table 29: AF300 Based Enzymatic Immunoassay Kit - Product Status
Table 30: AF300 Based Enzymatic Immunoassay Kit - Product Description
Table 31: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Diagnostic Assay - Breast Cancer - Product Status
Table 33: Diagnostic Assay - Breast Cancer - Product Description
Table 34: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 35: mRNA Based Diagnostic Assay - Breast Cancer - Product Status
Table 36: mRNA Based Diagnostic Assay - Breast Cancer - Product Description
Table 37: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: NMP66 Test - Product Status
Table 39: NMP66 Test - Product Description
Table 40: Allarity Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Epirubicin DRP Assay - Product Status
List of Figures
Figure 1: Breast Cancer - Pipeline Products by Stage of Development
Figure 2: Breast Cancer - Pipeline Products by Territory
Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Breast Cancer - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • A&G Pharmaceutical Inc
  • Abviva Inc (Inactive)
  • Accelerated Medical Diagnostics LLC
  • Acobiom
  • Affichem SA
  • AIT Austrian Institute of Technology GmbH
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Allarity Therapeutics A/S
  • Almac Diagnostic Services Ltd
  • Amarantus Bioscience Holdings Inc
  • AngioGenex Inc
  • Anixa Diagnostics Corporation
  • Armune BioScience Inc
  • Arno Therapeutics Inc
  • Assurance Biosciences, Inc. (Inactive)
  • Atossa Therapeutics Inc
  • Aurelium BioPharma Inc.
  • Autoimmune Technologies LLC
  • Avant Diagnostics Inc
  • Ayanda Biosystems SA (Inactive)
  • BARD1 Life Sciences Ltd
  • Baylor College of Medicine
  • BCAL Diagnostics Pty Limited
  • Becton Dickinson and Co
  • Biocrates Life Sciences AG
  • BioDesign Institute at Arizona State University
  • Biodesix Inc
  • BioGenex Laboratories Inc
  • Biolidics Ltd
  • BioMarCare Technologies Ltd
  • BioMark Diagnostics Inc
  • BioMarker Strategies LLC
  • bioMerieux SA
  • Biomoda Inc
  • Biosceptre International Ltd
  • BioSystems International
  • Caprion Biosciences Inc
  • Caris Life Sciences Inc
  • Celcuity Inc
  • Cellanyx Diagnostics, Inc.
  • CellXplore, Inc.
  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
  • Cepheid Inc
  • Ceres Nanosciences Inc
  • Cernostics Inc
  • China Sky One Medical Inc
  • Chronix Biomedical Inc
  • City of Hope
  • Clarient Inc
  • Cleveland Diagnostics Inc.
  • CompanDX Ltd
  • Courtagen Life Sciences Inc
  • Daan Gene Co Ltd
  • Dana-Farber Cancer Institute Inc
  • Dartmouth College
  • Dublin City University
  • Entopsis LLC
  • Eurobio Scientific SA
  • Exact Sciences Corp
  • Exosome Diagnostics Inc
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • Fina Biotech SL
  • Fluxion Biosciences Inc
  • Fournira Optime Diagnostics
  • French National Institute of Health and Medical Research
  • Genome Diagnostics Pvt Ltd
  • GenomicTree Co Ltd
  • Genoptix Inc
  • George Washington University
  • German Cancer Research Center
  • Ghent University
  • GlyCa BioSciences Inc
  • GlycoZym USA Inc
  • Guardant Health Inc
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hai Kang Life Corp Ltd
  • Health Discovery Corp
  • HealthTell Inc
  • Hebrew University of Jerusalem
  • Heragen Inc
  • Hitachi Chemical Diagnostics Inc
  • Houston Methodist Hospital
  • Ikonisys Inc
  • Immunovia AB
  • Inanovate Inc
  • Insight Genetics Inc
  • Inspirata Inc
  • Institute of Cancer Research
  • Institute of Molecular and Translational Medicine
  • IPDx Immunoprofiling Diagnostics GmbH
  • IRIS International Inc
  • Johns Hopkins University
  • Jonakee Cancer Research, Inc.
  • Kalgene Pharmaceuticals Inc
  • Leica Biosystems Nussloch GmbH
  • Liv Diagnostics AB
  • Louisville Bioscience Inc (Inactive)
  • MabCure Inc
  • Matrix-Bio Inc
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • MEDITE Cancer Diagnostics Inc
  • MedMira Inc
  • MedPacto Inc
  • Metabolomic Technologies Inc
  • MetaStat Inc
  • Milagen Inc
  • Morphotek Inc
  • MW Diagnostics Ltd
  • Nanostics Inc
  • NanoString Technologies Inc
  • New York University
  • Newcastle University
  • Nonagen Bioscience Corp
  • Novel Bio-spectrum Technologies Inc (Inactive)
  • Nuclea Biotechnologies Inc. (Inactive)
  • Nuvera Biosciences Inc
  • Olink Proteomics AB
  • Olympia Diagnostics Inc
  • Oncimmune (USA) LLC
  • OncoCyte Corp
  • Onconome, Inc. (Inactive)
  • OncoStem Diagnostics Pvt. Ltd
  • OncoVista Innovative Therapies Inc
  • Oregon Health & Science University
  • OSLER Diagnostics Ltd
  • OTraces Inc
  • Peri Rx Inc
  • Power3 Medical Products, Inc.
  • Precision Biologics Inc
  • Prelude Corp
  • PreMD Inc (Inactive)
  • Princeton University
  • Proplex Technologies Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomika (Inactive)
  • Purdue University
  • Rna Diagnostics Inc
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • RWTH Aachen University
  • Savicell Diagnostic Ltd.
  • Selventa Inc
  • Sengenics Corp Pte Ltd
  • Siemens Healthineers AG
  • SomaLogic Inc
  • Soricimed Biopharma Inc
  • Syantra Inc
  • Target Discovery Inc
  • Taxor Diagnostics, LLC
  • TechnoGenesys, Inc.
  • The University of Nottingham
  • Treos Bio Inc
  • Trinity College Dublin
  • Universal Diagnostics SL
  • University of Alberta
  • University of Bergen
  • University of Bonn
  • University of California San Diego
  • University of Colorado
  • University of Hong Kong
  • University of Kansas
  • University of Lyon
  • University of Minnesota
  • University of Missouri
  • University of Nebraska
  • University of Oxford
  • University of Pittsburgh
  • University of South Carolina
  • University of South Florida
  • University of Toledo
  • University of Turku
  • University of Wisconsin Madison
  • US Biomarkers Inc
  • Vala Sciences Inc
  • Vermillion Inc
  • Viomics Inc.
  • Vitruvian Biomedical Inc
  • VolitionRX Ltd
  • Washington University in St Louis
  • XEPTAGEN SpA
  • Zetiq Technologies Ltd
Note: Product cover images may vary from those shown